Search results with tag "Meddev 2"
Guidance MEDDEVs - European Commission
ec.europa.euMEDDEV 2.10/2 rev.1 (105 kB) Designation and monitoring of notified bodies within the framework of EC directives on medical devices annex 1 (119 kB), annex 2 (14 kB), annex 3 (16 kB), annex 4 (26 kB) April 2001 2.12 Post-Market surveillance . MEDDEV 2.12/1 rev.8 (763 kB) Guidelines on a medical devices vigilance system . January 2013
The top ten changes in MEDDEV 2.7.1 Rev 4 - BSI Group
www.bsigroup.comMEDDEV 2.7.1 Revision 4 has been released MEDDEV 2.7.1 Rev 4: Key changes and clarifications BSI MEDDEV 2.7.1 Rev 4 top 10 changes Call us now on +44 345 080 9000 Clarification: Frequency of updates to the Clinical Evaluation Report (CER). Clause 6.2.3 requires the CER to be updated at least annually for high risk or new devices, and every 2 to ...
Effective post-market surveillance - BSI Group
www.bsigroup.comPMS NBMed 2.12 Vigilance MEDDEV 2.12-1 Post-market clinical follow-up MEDDEV 2.12-1 Reactive PMS Proactive PMS Proactive Reactive • Customer surveys • Post CE mark clinical trials, including PMCF • Manufacturer sponsored device tracking/implant registries • Expert user groups (focus groups) • Customer complaints
Clinical Evaluation Report (CER) MDD 93/42/EEC …
www.qmed-consulting.comClinical Evaluation Report (CER) MDD 93/42/EEC and MEDDEV 2.7/1 ver. 4 Compliance Qmed Consulting A/S - Ørnevej 2, 4600 Køge, Denmark CER
EN 62304 - Frequently Asked Questions - Team NB
www.team-nb.orgSee MEDDEV 2.1/6 (chapter 2). 2.1.3 How does the standard distinguish between open and closed systems? Answer: There is no differentiation in the standard between closed or open systems. 2.1.4 Assuming all software has a medical purpose, does the standard apply to the
Medical Device White Paper Series Medical device clinical ...
www.medical-device-regulation.euMEDDEV 2.7/2 Rev 2 on clinical investigation validation and assessment by competent authorities MEDDEV 2.7/3 Rev. 3 on serious adverse event (SAE) reporting New requirements under the MDR The MDR introduces new requirements, which need …
MEDICAL DEVICES Guidance document Classification of ...
www.meddev.infoFor further guidance on clinical evaluation see MEDDEV 2.7.1 Rev.34. Pursuant to article 15.1, in case of devices intended for clinical investigations, the manufacturer shall notify the Competent Authorities of the Member States in which the investigations are to be conducted in accordance with section 2.2 …
EUROPEAN COMMISSION DG Health and Consumers ... - …
meddev.infoMEDDEV 2 12-1 rev. 8 Vigilance 6 d) devices that do not carry the CE-mark but where such INCIDENTs lead to CORRECTIVE ACTION(s) relevant to the devices mentioned in a), b) and c). These guidelines cover FIELD SAFETY CORRECTIVE ACTION relevant to CE-marked devices which are offered for sale or are in use within the EEA, Switzerland and Turkey. ...
MedDev 2.7.1 Rev 4 Medical Devices Regulation Clinical ...
www.medical-device-regulation.euMedDev 2.7.1 –6.2.3 Updating the clinical evaluation • on receipt of new information from PMS that has the potential to change the current evaluation • at least annually if the device carries significant risks or is not yet well established • every 2 to 5 years if the device is not expected to carry significant risks and is well established